Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Prev Sci. 2024 May;25(Suppl 2):291-315. doi: 10.1007/s11121-023-01605-2. Epub 2023 Nov 17.
Attention-deficit/hyperactivity disorder (ADHD) is characterized by persistent patterns of inattention, hyperactivity, and impulsiveness. Among US children and adolescents aged 3-17 years, 9.4% have a diagnosis of ADHD. Previous research suggests possible links between parental substance use and ADHD among children. We conducted a systematic review and meta-analysis of 86 longitudinal or retrospective studies of prenatal or postnatal alcohol, tobacco, or other parental substance use and substance use disorders and childhood ADHD and its related behavioral dimensions of inattention and hyperactivity-impulsivity. Meta-analyses were grouped by drug class and pre- and postnatal periods with combined sample sizes ranging from 789 to 135,732. Prenatal exposure to alcohol or tobacco and parent substance use disorders were consistently and significantly associated with ADHD among children. Other parental drug use exposures resulted in inconsistent or non-significant findings. Prevention and treatment of parental substance use may have potential for impacts on childhood ADHD.
注意缺陷多动障碍(ADHD)的特征是持续存在注意力不集中、多动和冲动的模式。在美国 3-17 岁的儿童和青少年中,有 9.4%被诊断为 ADHD。先前的研究表明,父母物质使用与儿童 ADHD 之间可能存在关联。我们对 86 项关于产前或产后酒精、烟草或其他父母物质使用和物质使用障碍以及儿童 ADHD 及其相关行为维度注意力不集中和多动冲动的纵向或回顾性研究进行了系统评价和荟萃分析。荟萃分析按药物类别和产前及产后时期分组,合并样本量从 789 到 135732 不等。产前暴露于酒精或烟草以及父母物质使用障碍与儿童 ADHD 明显相关。其他父母药物使用暴露则导致结果不一致或无统计学意义。预防和治疗父母的物质使用可能对儿童 ADHD 产生潜在影响。